Epidemiologic reviews

• 

  Año 2011, Número 33

  • Overview of screening: where we are and where we may be headed

    Russell Harris

    • Resumen

    págs. 1-6

    

  • cost effectiveness of colorectal cancer screenting

    Iris Lansdorp-Vogelaar, Amy B. knudsen, Hermann Brenner

    págs. 33-88

    

  • measuring mortality reductions in cancer screening trials

    James A. Hanley

    • Resumen

    págs. 36-45

    

  • risk assessment tools for identifying individuals at risk of developing type 2 diabetes

    Brian Buijsse

    • Resumen

    págs. 46-62

    

  • screening for type 2 diabetes and dysglycemia

    Justin B. Echouffo-Tcheugui

    • Resumen

    págs. 63-87

    

  • organized colorectal cancer screening in integrated health care systems

    Theodore R. Levin

    págs. 101-110

    

  • interpreting overdiagnosis estimates in population based mammography screening

    riaanne de gelder

    págs. 111-121

    

  • predisease: when does it make sense?

    Anthony J. Viera

    págs. 122-134

    

  • Psychosocial determinants of socioeconomic inequalities in cancer screening participation: a conceptual framework.

    C. Von Wagner

    págs. 135-147

    

  • genetic screening

    Wylie Burke, Beth Tarini

    págs. 148-164

    

  • breast cancer screening: a 35 year perspective

    Suzanne W. Fletcher

    págs. 165-175